Artificial Intelligence

MedCity Pivot Podcast: A Conversation With Unlearn.AI CEO About Clinical Trials

The founder and CEO of Unlearn.AI seeks to make clinical trials more efficient and less costly by leveraging its Digital Twin technology. If the company is successful, drugs could potentially be brought to market sooner and in a cost effective manner.

Season 3 of MedCity’s Pivot Podcast continues with a focus on how life sciences are being transformed. One area that has recently gone through major changes is the world of clinical trials as the industry finds ways to improve access, convenience and diversity by creating decentralized clinical trials.

Charles Fisher, founder and CEO of Unlearn.AI, is attempting to reimagine clinical trials even further by leveraging AI and Digital Twin Technologies. Learn more about his vision in the latest episode below.